MS China A Share
Name
Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
-6.2%
1 yr return
-13.2%
3 Yr Avg Return
-11.2%
5 Yr Avg Return
-11.8%
Net Assets
$398 M
Holdings in Top 10
56.7%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.75%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 121.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Closed-end mutual fund
Name
Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
XCAFX - Profile
Distributions
- YTD Total Return -6.2%
- 3 Yr Annualized Total Return -11.2%
- 5 Yr Annualized Total Return -11.8%
- Capital Gain Distribution Frequency N/A
- Net Income Ratio 0.42%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameMorgan Stanley China A Share Fund
-
Fund Family NameMorgan Stanley
-
Inception DateSep 28, 2006
-
Shares Outstanding21881465
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerGary Cheung
Fund Description
XCAFX - Performance
Return Ranking - Trailing
| Period | XCAFX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -6.2% | -16.7% | 11.8% | 64.62% |
| 1 Yr | -13.2% | -35.2% | 19.7% | 57.38% |
| 3 Yr | -11.2%* | -23.1% | 23.2% | 86.14% |
| 5 Yr | -11.8%* | -18.1% | 15.1% | 82.35% |
| 10 Yr | -3.6%* | -13.3% | 11.9% | 78.95% |
* Annualized
Return Ranking - Calendar
| Period | XCAFX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2022 | -26.2% | -40.5% | 25.8% | 46.67% |
| 2021 | -4.0% | -28.6% | 30.5% | 33.63% |
| 2020 | 0.7% | -6.6% | 33.6% | 96.97% |
| 2019 | 3.6% | -34.7% | 11.1% | 79.38% |
| 2018 | -5.3% | -13.7% | 32.0% | 54.88% |
Total Return Ranking - Trailing
| Period | XCAFX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -6.2% | -26.8% | 11.8% | 64.62% |
| 1 Yr | -13.2% | -35.2% | 19.7% | 57.38% |
| 3 Yr | -11.2%* | -23.1% | 23.2% | 86.14% |
| 5 Yr | -11.8%* | -16.2% | 15.1% | 82.35% |
| 10 Yr | -3.6%* | -13.3% | 11.9% | 91.23% |
* Annualized
Total Return Ranking - Calendar
| Period | XCAFX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2022 | -26.2% | -40.5% | 25.8% | 46.67% |
| 2021 | -4.0% | -28.6% | 30.5% | 33.63% |
| 2020 | 0.7% | -6.6% | 33.6% | 96.97% |
| 2019 | 3.6% | -34.7% | 11.1% | 79.38% |
| 2018 | -5.3% | -13.7% | 32.0% | 68.29% |
NAV & Total Return History
XCAFX - Holdings
Concentration Analysis
| XCAFX | Category Low | Category High | XCAFX % Rank | |
|---|---|---|---|---|
| Net Assets | 398 M | 1.4 M | 6.58 B | 16.03% |
| Number of Holdings | 27 | 6 | 961 | 96.09% |
| Net Assets in Top 10 | 234 M | 706 K | 4.22 B | 15.63% |
| Weighting of Top 10 | 56.69% | 6.6% | 99.9% | 19.53% |
Top 10 Holdings
- China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
- China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
- China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
- China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
- China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
- China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
- China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
- China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
- China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
- China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
Asset Allocation
| Weighting | Return Low | Return High | XCAFX % Rank | |
|---|---|---|---|---|
| Stocks | 88.11% | 0.00% | 102.18% | 98.45% |
| Cash | 11.89% | -2.18% | 11.89% | 0.78% |
| Preferred Stocks | 0.00% | 0.00% | 0.00% | 41.41% |
| Other | 0.00% | 0.00% | 47.32% | 51.56% |
| Convertible Bonds | 0.00% | 0.00% | 0.15% | 45.31% |
| Bonds | 0.00% | 0.00% | 69.90% | 45.74% |
XCAFX - Expenses
Operational Fees
| XCAFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.75% | 0.09% | 3.14% | 10.00% |
| Management Fee | 1.50% | 0.09% | 1.50% | 100.00% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
| Administrative Fee | 0.08% | 0.06% | 0.26% | 12.00% |
Sales Fees
| XCAFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
| XCAFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 2.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| XCAFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 121.00% | 4.00% | 278.00% | 90.72% |
XCAFX - Distributions
Dividend Yield Analysis
| XCAFX | Category Low | Category High | XCAFX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 22.09% | 67.94% |
Dividend Distribution Analysis
| XCAFX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annually | Annually | Monthly | Annually |
Net Income Ratio Analysis
| XCAFX | Category Low | Category High | XCAFX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | 0.42% | -1.76% | 4.74% | 38.40% |
Capital Gain Distribution Analysis
| XCAFX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Jul 14, 2017 | $0.034 | OrdinaryDividend |
| Oct 01, 2015 | $0.006 | OrdinaryDividend |
| Jul 13, 2007 | $0.157 | OrdinaryDividend |
XCAFX - Fund Manager Analysis
Managers
Gary Cheung
Start Date
Tenure
Tenure Rank
Jan 30, 2017
5.33
5.3%
Gary focuses on China & China A shares for our Asian Equity strategies. He joined Morgan Stanley in 2008 and has 14 years of investment experience. Prior to joining the firm, Gary was a macro equity analyst at Tudor Investment. Previously, Gary was an investment banking analyst at Credit Suisse focusing on corporate financial strategies. Gary received a B.S. summa cum laude in industrial and management engineering from Rensselaer Polytechnic Institute, and an M.S. in financial engineering from Columbia University. He holds the Chartered Financial Analyst designation.
Leon Sun
Start Date
Tenure
Tenure Rank
Mar 31, 2021
1.17
1.2%
Leon is an investor on the Global Emerging Markets team, and the lead portfolio manager for the China strategies. Leon is also a co-portfolio manager for the Asia regional strategies. He joined Morgan Stanley in 2021 and has 23 years of investment experience. Prior to joining the firm, he worked as a senior portfolio manager and head of investment for China and Hong Kong at Nomura Asset Management. He was also an investment analyst at Martin Currie and a credit officer at Bank of China. Leon received a B.A. in English from Shanghai International Studies University and a Msc. in finance and investment from The University of Edinburgh. He holds the Chartered Financial Analyst designation.
Amay Hattangadi
Start Date
Tenure
Tenure Rank
Apr 23, 2021
1.1
1.1%
Amay is Managing Director of MSIM Company. He joined Morgan Stanley in 1997 and has 21 years of investment experience. Previously, he was a portfolio administrator. Amay received a Bachelor of Commerce degree from the University of Mumbai. He is an Associate Member of the Institute of Chartered Accountants of India. He holds the Charted Financial Analyst designation.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.09 | 28.32 | 4.11 | 3.22 |